Research Advances and Application Prospect of Low-Temperature Plasma in Tumor Immunotherapy
Source abstract
Abstract
As an emerging technology, low-temperature plasma (LTP) is widely used in medical fields such as sterilization, wound healing, stomatology, and cancer treatment. Great achievements have been made in tumor therapy. In vitro and in vivo studies have shown that LTP has anti-tumor effects, and LTP is selective to tumor cells. Studies in recent years have found that LTP can activate dendritic cells (DC), macrophages, T cells, and other immune cells to achieve anti-tumor effects. This paper reviews the current status of tumor immunotherapy, the application of LTP in antitumor therapy, the activation of antitumor immunity by LTP, the possible mechanism of LTP in antitumor immunity, and meanwhile analyses the prospect of applying LTP in tumor immunotherapy.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Plasma Applications and Diagnostics · Nanoplatforms for cancer theranostics · CAR-T cell therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Public Health, Xi’an Jiaotong University, Xi’an 710061, China
Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi’an 710061, China
School of Electrical Engineering, Xi’an Jiaotong University, Xi’an 710049, China
Funding
the General Program of National Natural Science
References (51)
Show source-provided references
1. Low-Temperature Plasma Suppresses Proliferation and Induces Apoptosis in Lung Cancer Cells by Regulating the miR-203a/BIRC5 Axis10.2147/OTT.S244853 ↗
2. Cold physical plasma selects for specific T helper cell subsets with distinct cells surface markers in a caspase-dependent and NF-κB-independent manner10.1002/ppap.201600080 ↗
3. Why Target Immune Cells for Plasma Treatment of Cancer10.1007/s11090-015-9676-z ↗
4. The Emerging Landscape of Immune Cell Therapies10.1016/j.cell.2020.03.001 ↗
5. Dendritic cells based immunotherapy
6. Lupo, K.B., and Matosevic, S. (2019). Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy. Cancers, 11.10.3390/cancers11060769 ↗
7. Current concepts in the diagnosis and management of cytokine release syndrome10.1182/blood-2014-05-552729 ↗
8. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade10.1126/science.aaf1490 ↗
9. Tanaka, H., Mizuno, M., Ishikawa, K., Toyokuni, S., Kajiyama, H., Kikkawa, F., and Hori, M. (2021). Cancer treatments using low-temperature plasma. Curr. Med. Chem., 29.10.2174/0929867328666210629121731 ↗
10. Low temperature plasmas as emerging cancer therapeutics: The state of play and thoughts for the future10.1007/s13277-016-4911-7 ↗
11. Floating Electrode Dielectric Barrier Discharge Plasma in Air Promoting Apoptotic Behavior in Melanoma Skin Cancer Cell Lines10.1007/s11090-007-9048-4 ↗
12. Helium low temperature plasma induced HepG2 cells autophagy through ROS-mediated PI3K/AKT/mTOR/P70s6k signaling pathway10.1063/1.5116292 ↗
13. Low-temperature plasma induced melanoma apoptosis by triggering a p53/PIGs/caspase-dependent pathwayin vivoandin vitro10.1088/1361-6463/ab1ca9 ↗
14. Binenbaum, Y., Ben-David, G., Gil, Z., Slutsker, Y.Z., Ryzhkov, M.A., Felsteiner, J., Krasik, Y.E., and Cohen, J.T. (2017). Cold Atmospheric Plasma, Created at the Tip of an Elongated Flexible Capillary Using Low Electric Current, Can Slow the Progression of Melanoma. PLoS ONE, 12.10.1371/journal.pone.0169457 ↗
15. Utilizing the micron sized non-thermal atmospheric pressure plasma inside the animal body for the tumor treatment application10.1038/srep29048 ↗
16. Alimohammadi, M., Golpur, M., Sohbatzadeh, F., Hadavi, S., Bekeschus, S., Niaki, H.A., Valadan, R., and Rafiei, A. (2020). Cold Atmospheric Plasma Is a Potent Tool to Improve Chemotherapy in Melanoma In Vitro and In Vivo. Biomolecules, 10.10.3390/biom10071011 ↗
17. ROS from Physical Plasmas: Redox Chemistry for Biomedical Therapy10.1155/2019/7017363 ↗
18. Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells10.1038/s41598-019-40637-z ↗
19. Differential sensitivity of lymphocyte subpopulations to non-thermal atmospheric-pressure plasma10.1016/j.imbio.2011.10.017 ↗
20. Effects of Low-Temperature Atmospheric Air Plasmas on the Activity and Function of Human Lymphocytes10.1002/ppap.200700174 ↗
21. Human Mononuclear Cell Survival and Proliferation is Modulated by Cold Atmospheric Plasma Jet10.1002/ppap.201300008 ↗
22. Physical plasma and leukocytes-immune or reactive?10.1515/hsz-2018-0224 ↗
23. Uniform Nanosecond Pulsed Dielectric Barrier Discharge Plasma Enhances Anti-Tumor Effects by Induction of Immunogenic Cell Death in Tumors and Stimulation of Macrophages10.1002/ppap.201500139 ↗
24. The immune contexture in human tumours: Impact on clinical outcome10.1038/nrc3245 ↗
25. Van Loenhout, J., Flieswasser, T., Freire Boullosa, L., De Waele, J., Van Audenaerde, J., Marcq, E., Jacobs, J., Lin, A., Lion, E., and Dewitte, H. (2019). Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells. Cancers, 11.10.3390/cancers11101597 ↗
26. Tumor cytotoxicity and immunogenicity of a novel V-jet neon plasma source compared to the kINPen10.1038/s41598-020-80512-w ↗
27. Tomic, S., Petrovic, A., Puac, N., Skoro, N., Bekic, M., Petrovic, Z.L., and Colic, M. (2021). Plasma-Activated Medium Potentiates the Immunogenicity of Tumor Cell Lysates for Dendritic Cell-Based Cancer Vaccines. Cancers, 13.10.3390/cancers13071626 ↗
28. Bekeschus, S., Meyer, D., Arlt, K., von Woedtke, T., Miebach, L., Freund, E., and Clemen, R. (2021). Argon Plasma Exposure Augments Costimulatory Ligands and Cytokine Release in Human Monocyte-Derived Dendritic Cells. Int. J. Mol. Sci., 22.10.3390/ijms22073790 ↗
29. Progress in signaling pathways of macrophage M1/2 polarization
30. Reis-Sobreiro, M., Teixeira da Mota, A., Jardim, C., and Serre, K. (2021). Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages. Cells, 10.10.3390/cells10092364 ↗
31. Kaushik, N.K., Kaushik, N., Adhikari, M., Ghimire, B., Linh, N.N., Mishra, Y.K., Lee, S.-J., and Choi, E.H. (2019). Preventing the Solid Cancer Progression via Release of Anticancer-Cytokines in Co-Culture with Cold Plasma-Stimulated Macrophages. Cancers, 11.10.3390/cancers11060842 ↗
32. A myeloid and lymphoid infiltrate in murine pancreatic tumors exposed to plasma-treated medium10.1016/j.cpme.2018.07.001 ↗
33. Plasma Stimulation of Migration of Macrophages10.1002/ppap.201400168 ↗
34. Khabipov, A., Freund, E., Liedtke, K.R., Kading, A., Riese, J., van der Linde, J., Kersting, S., Partecke, L.I., and Bekeschus, S. (2021). Murine Macrophages Modulate Their Inflammatory Profile in Response to Gas Plasma-Inactivated Pancreatic Cancer Cells. Cancers, 13.10.3390/cancers13112525 ↗
35. Cancer-related circulating and tumor-associated neutrophils—Subtypes, sources and function10.1111/febs.14524 ↗
36. Neutrophil extracellular trap formation is elicited in response to cold physical plasma10.1189/jlb.3A0415-165RR ↗
37. Systemic study on the safety of immuno-deficient nude mice treated by atmospheric plasma-activated water10.1088/2058-6272/aa9842 ↗
38. Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo10.1038/s41598-018-37169-3 ↗
39. Bekeschus, S., Ressel, V., Freund, E., Gelbrich, N., Mustea, A., and Stope, M.B. (2020). Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity. Antioxidants, 9.10.3390/antiox9040323 ↗
40. Rödder, K., Moritz, J., Miller, V., Weltmann, K.-D., Metelmann, H.-R., Gandhirajan, R., and Bekeschus, S. (2019). Activation of Murine Immune Cells upon Co-culture with Plasma-treated B16F10 Melanoma Cells. Appl. Sci., 9.10.3390/app9040660 ↗
41. Yan, D., Malyavko, A., Wang, Q., Ostrikov, K.K., Sherman, J.H., and Keidar, M. (2021). Multi-Modal Biological Destruction by Cold Atmospheric Plasma: Capability and Mechanism. Biomedicines, 9.10.3390/biomedicines9091259 ↗
42. Arndt, S., Fadil, F., Dettmer, K., Unger, P., Boskovic, M., Samol, C., Bosserhoff, A.K., Zimmermann, J.L., Gruber, M., and Gronwald, W. (2021). Cold Atmospheric Plasma Changes the Amino Acid Composition of Solutions and Influences the Anti-Tumor Effect on Melanoma Cells. Int. J. Mol. Sci., 22.10.3390/ijms22157886 ↗
43. Cold atmospheric plasma generated reactive species aided inhibitory effects on human melanoma cells: An in vitro and in silico study10.1038/s41598-020-60356-0 ↗
44. Toward understanding the selective anticancer capacity of cold atmospheric plasma--a model based on aquaporins (Review)10.1116/1.4938020 ↗
45. Low temperature plasma irradiation products of sodium lactate solution that induce cell death on U251SP glioblastoma cells were identified10.1038/s41598-021-98020-w ↗
46. Uniform and non-uniform modes of nanosecond-pulsed dielectric barrier discharge in atmospheric air: Fast imaging and spectroscopic measurements of electric field10.1088/0022-3727/47/25/252003 ↗
47. Anti-tumor immune response induced by nanosecond pulsed streamer discharge in mice10.1088/1361-6463/aa5dbb ↗
48. Immunogenic cell death in colon cancer prevention and therapy10.1002/mc.23183 ↗
49. Lin, A., Truong, B., Patel, S., Kaushik, N., Choi, E.H., Fridman, G., Fridman, A., and Miller, V. (2017). Nanosecond-Pulsed DBD Plasma-Generated Reactive Oxygen Species Trigger Immunogenic Cell Death in A549 Lung Carcinoma Cells through Intracellular Oxidative Stress. Int. J. Mol. Sci., 18.10.3390/ijms18050966 ↗
50. Molecular mechanisms involved in dendritic cell dysfunction in cancer10.1007/s00018-016-2317-8 ↗
51. Non-thermal plasma induces immunogenic cell death in vivo in murine CT26 colorectal tumors10.1080/2162402X.2018.1484978 ↗